Nanotechnology in Medicine: From Molecules to Humans

本次ECI医学纳米技术会议的中心目标是为 该领域研究人员之间的全球讨论，总体目标是帮助机械学 了解纳米技术引起的细胞和分子相互作用/反应，以及我们如何 可以更好地利用这些理解来为早期产生高效的纳米技术 人类疾病的检测、成像和治疗。会议将于2016年7月3日至8日在北京举行 施洛斯·赫恩斯坦，奥地利，Lola Eniola-Adeeso教授(密歇根大学)担任会议 主席和Paolo Decuzzi博士(意大利理工学院)担任共同主席。这次会议将把 来自全球的生物学家、材料科学家、物理学家、工程师和临床科学家。这 会议将代表一个论坛，讨论在以下领域的新机遇和挑战 纳米技术在医学上的应用，并促进科学家与 不同的背景和专业知识。因此，医学中的纳米技术ECI会议适合 国家生物医学成像和生物工程研究所(NIBIB)的使命：通过以下方式改善健康 以整合的方式引领和加速生物医学技术的发展和应用 将物理和工程科学与生命科学结合起来，以促进基础研究和医疗保健。 本次会议的主要议题包括用于(1)细胞研究的纳米技术的发展 黏附、生长和分化；(2)诊断、治疗和组织工程。因此，我们 预计本次会议的科学互动将促进“早期技术的发展” 疾病检测和健康状况评估。

The central objective of this ECI conference on Nanotechnology in Medicine is to provide a platform for global discussion amongst researchers in the field with the overall goal of aiding the mechanistic understanding of cellular and molecular interactions/responses induced by nanotechnologies and how we can better exploit these understandings to generate highly effective nanotechnologies for the early detection, imaging and treatment of human diseases. The conference will be held July 3 – 8, 2016 in Schloss Hernstein, Austria with Prof. Lola Eniola-Adefeso (University of Michigan) serving as conference chair and Dr. Paolo Decuzzi (Italian Institute of Technology) as co-chair. The conference will bring together biologists, materials scientists, physicists, engineers and clinical scientists from across the globe. This conference will represent a forum to discuss new opportunities and challenges in the field of nanotechnology in medicine and to foster the development of synergic collaborations among scientists with diverse backgrounds and expertise. As such, the Nanotechnology in Medicine ECI conference fit the mission of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) “to improve health by leading the development and accelerating the application of biomedical technologies by the integration of the physical and engineering sciences with the life sciences to advance basic research and medical care.” The key topics to be covered in this conference include development of nanotechnology for (1) study of cell adhesion, growth and differentiation; and (2) for diagnostic, therapeutics and tissue engineering. Thus, we anticipate that the scientific interactions at this conference will foster “development of technologies for early disease detection and assessment of health status.